Reference
The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥75 years): a retrospective, pharmacovigilance study Cardiovascular Diabetology 22: 24 Jan 2023. Available from: URL: https://doi.org/10.1186/s12933-023-01743-5
Rights and permissions
About this article
Cite this article
Risk of SGLT2i-related AEs not greater in elderly versus younger adults. Reactions Weekly 1942, 12 (2023). https://doi.org/10.1007/s40278-023-32621-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-32621-6